Vital Signs: Breast Cancer Screening Among Women Aged 50-74 Years - United States, 2008
Overview
Affiliations
Background: Breast cancer remains the second leading cause of cancer deaths for women in the United States. Screening with treatment has lowered breast cancer mortality.
Methods: Every 2 years, CDC uses Behavioral Risk Factor Surveillance System data to estimate mammography prevalence in the United States. Up-to-date mammography prevalence is calculated for women aged 50-74 years who report they had the test in the preceding 2 years.
Results: For 2008, overall, age-adjusted, up-to-date mammography prevalence for U.S. women aged 50-74 years was 81.1%, compared with 81.5% in 2006. Among the lowest prevalences reported were those by women aged 50-59 years (79.9%), persons who did not finish high school (72.6%), American Indian/Alaska Natives (70.4%), those with annual household income <$15,000 (69.4%), and those without health insurance (56.3%). Highest mammography prevalence was among residents of the northeastern United States.
Conclusions: In recent years, mammography rates have plateaued. Critical gaps in screening remain for certain racial/ethnic groups and lower socioeconomic groups, and for the uninsured.
Implications For Public Health Practice: Health-care reform is likely to increase access by increasing insurance coverage and by reducing out-of-pocket costs for mammography screening. Widespread implementation of evidence-based interventions also will be needed to increase screening rates. These include patient and provider reminders to schedule a mammogram, use of small media (e.g., videos, letters, brochures, and flyers), one-on-one education of women, and reduction of structural barriers (e.g., more convenient hours and attention to language, health literacy, and cultural factors).
Narcisse M, Shah S, Hallgren E, Felix H, Schootman M, McElfish P Prev Med. 2023; 173:107545.
PMID: 37201597 PMC: 10773561. DOI: 10.1016/j.ypmed.2023.107545.
A Motivational Interviewing Intervention to Promote CRC Screening: A Pilot Study.
Adegboyega A, Aleshire M, Wiggins A, Palmer K, Hatcher J Cancer Nurs. 2020; 45(1):E229-E237.
PMID: 33252406 PMC: 8144243. DOI: 10.1097/NCC.0000000000000905.
Health-related Factors Associated with Adherence to Breast Cancer Screening.
Schoofs J, Krijger K, Vandevoorde J, Devroey D J Midlife Health. 2017; 8(2):63-69.
PMID: 28706406 PMC: 5496282. DOI: 10.4103/jmh.JMH_71_15.
Pandhi N, Schumacher J, Thorpe C, Smith M BMJ Open. 2016; 6(3):e009738.
PMID: 26951211 PMC: 4785317. DOI: 10.1136/bmjopen-2015-009738.
Mortel M, Rauscher G, Murphy A, Hoskins K, Warnecke R Cancer Epidemiol Biomarkers Prev. 2015; 24(10):1599-606.
PMID: 26199340 PMC: 4592461. DOI: 10.1158/1055-9965.EPI-15-0305.